A strategic theme centered on strengthening the gastrointestinal disease area, from the upper to lower gastrointestinal tract, as a consistent focus area, then leveraging its business and R&D platform to expand into oncology as the next area of development. This also includes expanding product sales in the gastrointestinal area.